Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab.
Istituto di Ematologia, Università Cattolica del Sacro Cuore, Rome, Italy.
Luca
L
Laurenti
Michela
M
Tarnani
Idanna
I
Innocenti
Gustavo
G
Savino
Remo
R
Battendieri
Luigi Maria
LM
Larocca
Patrizia
P
Chiusolo
Federica
F
Sorà
Simona
S
Sica
Dimitar
D
Efremov
Giuseppe
G
Leone
D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005142:Eyelid Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab